Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Laboratoires Thea |
---|---|
Information provided by: | Laboratoires Thea |
ClinicalTrials.gov Identifier: | NCT00357019 |
To assess the clinical and biological efficacity of preservative free NAAGA eyes drops in vernal keratoconjunctivitis
Condition | Intervention | Phase |
---|---|---|
Keratoconjunctivitis, Vernal |
Drug: N-acetyl-aspartyl-glutamate (NAAXIA Sine) |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis |
Study Start Date: | April 2001 |
Estimated Study Completion Date: | October 2002 |
The objective of this pilot study is to evaluate the clinical and biological efficacy of preservative free NAAGA eyedrops in VKC –by in particular the levels of ECP and MPO in tears- comparatively to the activity of levocabastine eyedrops.
Ages Eligible for Study: | 4 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | TPO 09/99 NAAXIA SINE Phase IV |
Study First Received: | July 26, 2006 |
Last Updated: | July 26, 2006 |
ClinicalTrials.gov Identifier: | NCT00357019 |
Health Authority: | Italy: Ministry of Health |
Corneal Diseases Conjunctivitis, Allergic Eye Diseases Conjunctivitis Keratoconjunctivitis Vernal keratoconjunctivitis Conjunctival Diseases |
Histamine Hypersensitivity N-acetyl-1-aspartylglutamic acid Hypersensitivity, Immediate Keratitis Histamine phosphate |
Respiratory System Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Immune System Diseases Physiological Effects of Drugs Anti-Asthmatic Agents Histamine Agents Anti-Allergic Agents Protective Agents |
Neuroprotective Agents Pharmacologic Actions Histamine Antagonists Autonomic Agents Therapeutic Uses Histamine H1 Antagonists Peripheral Nervous System Agents Central Nervous System Agents Bronchodilator Agents |